
Péptidos
Los péptidos son cadenas cortas de aminoácidos unidas por enlaces peptídicos, que desempeñan papeles importantes como moléculas biológicas en los procesos celulares. Funcionan como hormonas, neurotransmisores y moléculas de señalización, y se utilizan ampliamente en aplicaciones terapéuticas y diagnósticas. Los péptidos también son cruciales en la investigación para estudiar las interacciones de proteínas, actividades enzimáticas y vías de señalización celular. En CymitQuimica, ofrecemos una amplia selección de péptidos de alta calidad para apoyar sus necesidades de investigación y desarrollo en biotecnología y farmacéutica.
Subcategorías de "Péptidos"
Productos de "Péptidos"
Ordenar por
Compstatin control peptide acetate
CAS:Compstatin control peptide acetate is an inhibitor of complement protein C3 by binding and inhibiting the cleavage of complement C3.Fórmula:C66H101N23O17Pureza:99.02%Forma y color:Odour SolidPeso molecular:1488.65H-SYSMEHF^RWGKPV-NH2
Peptide H-SYSMEHF^RWGKPV-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SYSMEHF^RWGKPV-NH2 include the following: The Plasma Membrane as a Reservoir, Protective Shield, and Light-Triggered Launch Pad for Peptide Therapeutics CP O'Banion , LT Nguyen, Q Wang - Angewandte , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ange.201508767 Biotinylation of peptides/proteins using biocytin hydrazide BS Lee, S Krishnanchettiar, SS Lateef - Journal of the Chinese , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jccs.200700076 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481H-LDELLQSQIEK-OH
Peptide H-LDELLQSQIEK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LDELLQSQIEK-OH include the following: A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials JR Whiteaker , L Zhao, RM Schoenherr, D Huang- Frontiers in ..., 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2023.1168710/fullDPC AJ1951 acetate
DPC-AJ1951 acetate: 14-amino acid peptide, potent PTH/PPR agonist, tested for bone resorption activity ex vivo/in vivo.Fórmula:C78H131N23O21Pureza:96.63%Forma y color:SolidPeso molecular:1727.02HLA-A*02:01 MAGE-A1 (278-286)
HLA-A*02 is a class I major histocompatibility complex (MHC) allele which is part of the HLA-A group of human major histocompatibility complex (MHC) leukocyte antigens (HLA). HLA-A is a human MHC class I cell surface receptor and is involved in presenting short polypeptides to the immune system. These polypeptides are typically 7-11 amino acids in length and originate from proteins being expressed by the cell. Cytotoxic T cells in the blood "read" the peptide presented by the complex and should only bind to non-self peptides. If binding occurs, a series of events is initiated culminating in cell death via apoptosis. Melanoma-associated antigen 1 (MAGE-A1) is part of a well-characterized group of cancer/testis antigens (CTA) that are encoded as a separate cluster on the X chromosome. MAGE-I antigens are mainly expressed in highly proliferating cells, such as cancer cells and therefore may be ideal targets for cancer immunotherapy. Expression of MAGEs has been reported several types of cancer including: lung- breast- thyroid- colon- stomach- liver and bladder where MAGE-A is considered to be a poor prognostic factor.This peptide corresponds to part of the MAGE-A1 sequence which is presented on the MHC class I antigen HLA-A*02.Peso molecular:1,089.7 g/molMelanocyte Protein PMEL 17 (44-59) (human, bovine, mouse)
Custom research peptide; min purity 95%.Fórmula:C95H137N27O29Pureza:Min. 95%Peso molecular:2,105.32 g/molBiotin-Phosphorylated MBP (94-102)
Catalogue peptide; min. 95% purityFórmula:C49H85N20O15SPeso molecular:1,273.41 g/molMAGEA9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA9 antibody, catalog no. 70R-8268Pureza:Min. 95%Osteopontin Heavy Tryptic Peptide Standard (4nmol)
For Protein Identification and QuantitationPureza:Min. 95%CTTHWGFTLC, CYCLIC
CAS:CTT Gelatinase Inhibitor peptide blocks MMP-2/9, hindering cancer by stopping tumor growth.Fórmula:C52H71N13O14S2Pureza:98%Forma y color:SolidPeso molecular:1166.33Sun A gene (2-61), 60 amino acid polypeptide
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolLOC115648 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CCT8L2 antibody, catalog no. 70R-5062Pureza:Min. 95%Peptide YY(3-36), PYY, human
Custom research peptide; min purity 95%.Fórmula:C180H279N53O54Pureza:Min. 95%Peso molecular:4,049.55 g/mol5Fam-DRVYIHPF-OH
Peptide 5Fam-DRVYIHPF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 5Fam-DRVYIHPF-OH include the following: The effect of the secondary structure on dissociation of peptide radical cations: Fragmentation of angiotensin III and its analogues Z Yang , C Lam, IK Chu , J Laskin - The Journal of Physical , 2008 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jp805226x The ornithine effect in peptide cation dissociation WM McGee, SA McLuckey - Journal of Mass Spectrometry, 2013 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.3233 New Substrates for Enteropeptidase: I. Biologically Active Hepta-, Octa-, and Nonapeptides VV Likhareva, BV Vas' kovskii, NE Shepel' - Russian Journal of , 2003 - Springerhttps://link.springer.com/article/10.1023/A:1023200230022 Synthetic model and bioactive peptides as potential substrates for enteropeptidase VV Likhareva, AG Mikhailova, BV Vaskovsky - Letters in Peptide , 2002 - Springerhttps://link.springer.com/article/10.1023/A:1024146528313 Mass spectrometry analysis of synthetically myristoylated peptides TS Chen, JD Yoder, DE Hruby - European Journal of Mass , 2004 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1255/ejms.652 Design of substrate-type ACE inhibitory pentapeptides with an antepenultimate C-terminal proline for efficient release of inhibitory activity S Rao, S Liu, T Ju, W Xu, G Mei, Y Xu - Biochemical engineering , 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1369703X11002634 Novel copoly (styrene-divinylbenzene)-resins with different phenylmethylamine groups for use in peptide synthesis method S EG Souza, L Malavolta , EM Cilli - Protein and Peptide , 2015 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ppl/2015/00000022/00000005/art00003 Department zyxwvutsrqponmlkjihgfed QUM GU, GD PRESTWICH - academia.eduhttps://www.academia.edu/download/71325798/j.1399-3011.1997.tb01155.x20211004-14905-ztg6w4.pdf Photochemical conjugation of peptides to carrier proteins using 1,2,3-thiadiazole-4-carboxylic acid Immunoreactivity of free C-terminal epitope with specific PR HANSEN , H FLYGE, A HOLM - Journal of Peptide , 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1996.tb01092.x HIV Fusion Peptides Significantly Soften Lipid Bilayers P Shchelokovskyy , S Tristram-Nagle , R Lipowsky - Biophysical , 2010 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(09)03330-X.pdf Spectroscopic Studies of the Interaction of Native and TOAC-Labeled Peptide Hormones with Model Membranes: Angiotensin II N MaracaÂn , E Poletti , CR Nakaie , S Schreier - Biophysical Journal, 2010 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(09)03327-X.pdf )-2, 2, 5, 5-tetramethylpyrrolidine-N-oxyl-3-amino-4-carboxylic acid]: A novel protected spin labeled beta-amino acid for peptide and protein chemistry M Tominaga, SR Barbosa, EF Poletti - Chemical and , 2001 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/cpb/49/8/49_8_1027/_article/-char/ja/ Screening for silver nanoparticle-binding peptides by using a peptide array M Kuboyama, R Kato , M Okochi, H Honda - Biochemical engineering , 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1369703X12001180 Tools for the Identification of Receptor Dimmers: Synthesis and Biological Evaluation of On-Resin Dimerized, Photosensitive Analogues of Angiotensin II KA Therrien, M Deraaca«t, A Dubois, L Rihakova - Peptides: The Wave of , 2001 - Springerhttps://link.springer.com/chapter/10.1007/978-94-010-0464-0_414 Energetics and dynamics of dissociation of deprotonated peptides: Fragmentation of angiotensin analogs J Laskin , Z Yang - International Journal of Mass Spectrometry, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1387380611002570 Fragmentation energetics for angiotensin II and its analogs from time-and energy-resolved surface-induced dissociation studies J Laskin , TH Bailey, JH Futrell - International Journal of Mass Spectrometry, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1387380604001174 Comparative Investigation of the Cleavage Step in the Synthesis of Model Peptide Resins: Implications for Nalpha-9-Fluorenylmethyloxycarbonyl-Solid Phase Peptide GN Jubilut, EM Cilli , E Crusca Jr , EH Silva - Chemical and , 2007 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/cpb/55/3/55_3_468/_article/-char/ja/ Use of the same polymer for synthesis and purification of peptides EH Silva, A Etchegaray , RSH Carvalho - Journal of the Brazilian , 2005 - SciELO Brasilhttps://www.scielo.br/j/jbchs/a/jjp9dx7pbsZSwQS64xHBmkm/?lang=en&format=html Gamma ray irradiation of the vasoactive peptide bradykinin reveals a residue-and position-dependent structural modification DT Nardi, JC Rosa , GN Jubilut, A Miranda - Journal of Peptide , 2010 - Springerhttps://link.springer.com/article/10.1007/s10989-010-9205-0 Antiplasmodial Activity of Angiotensin II Analogs DM de Freitas, VXO Junior - of the 24 th American Peptide , 2015 - researchgate.nethttps://www.researchgate.net/profile/Vani-Junior/publication/299917946_Antiplasmodial_Activity_of_Angiotensin_II_Analogs/links/573df8a408ae9f741b2fff1e/Antiplasmodial-Activity-of-Angiotensin-II-Analogs.pdf Comparison of methods to examine the endogenous peptides of fetal calf serum D Williams, P Zhu, P Bowden , C Stacey, M McDonell - Clinical Proteomics, 2006 - Springerhttps://link.springer.com/article/10.1385/CP:2:1:67 A Photolabile Thiol Protecting Group for Cellular Studies D Abate-Pella, N Zeliadt, D Mullen - Peptides: Breaking - books.google.comhttps://books.google.com/books?hl=en&lr=&id=sl1PAgAAQBAJ&oi=fnd&pg=PA362&dq=(%22DRVYIHPF%22+OR+%225Fam-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH%22+OR+%225Fam-DRVYIHPF-OH%22)+AND+peptide&ots=9_qVAwUb6F&sig=VEhy6PPhcw0NEgXcAxRZvjUvsdQ Intermolecular condensation products formed during the pyrolysis of peptides C Liu, F Basile - Journal of analytical and applied pyrolysis, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165237011001045 Characterization of the dehydration products due to thermal decomposition of peptides by liquid chromatography-tandem mass spectrometry C Liu, E Topchiy , T Lehmann - Journal of Mass , 2015 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.3570 Structural and activity changes in three bioactive anuran peptides when Asp is replaced by isoAsp AN Calabrese , K Markulic, IF Musgrave , H Guo - Peptides, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978112004329 Linear Peptides Related to Angiotensin II with Antiplasmodial Activity AF Silva , MDT Torres, LS Silva , FL Alves , AAS Pinheiro - researchgate.nethttps://www.researchgate.net/profile/Margareth-Capurro/publication/299917711_Linear_Peptides_Related_to_Angiotensin_II_with_Antiplasmodial_Activity/links/573b1e1708ae9f741b2d7701/Linear-Peptides-Related-to-Angiotensin-II-with-Antiplasmodial-Activity.pdfN-Acetyl-D-phenylalanine
CAS:Fórmula:C11H13NO3Pureza:>98.0%(T)(HPLC)Forma y color:White powder to crystalPeso molecular:207.23POLR2K Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of POLR2K antibody, catalog no. 70R-2961Pureza:Min. 95%Ac-Gly-Ala-Lys(Ac)-AMC
CAS:Please enquire for more information about Ac-Gly-Ala-Lys(Ac)-AMC including the price, delivery time and more detailed product information at the technical inquiry form on this pageFórmula:C25H33N5O7Pureza:Min. 98 Area-%Forma y color:PowderPeso molecular:515.56 g/molAD01
AD01 is a derivative of the FK506 binding protein-like (FKBPL), and exerts potent anti-angiogenic activity in vitro and in vivo to control tumour growth. Recent studies have shown that AD-01 inhibits Rac-1 activity, and up-regulates RhoA and the actin binding proteins, profilin and vinculin. In this way, the anti-angiogenic proteins, FKBPL, and AD-01, offer a promising and alternative approach for targeting both CD44 positive tumours and vasculature networks. Recent clinical studies have shown that AD01 and other FKBPL-based peptides may offer an alternative for targeting treatment-resistant breast cancer stem cells.Peso molecular:2,574.3 g/molH-YMLDL^QPETT-OH
Peptide H-YMLDL^QPETT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMLDL^QPETT-OH include the following: T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor YS Lee, TS Kim, DK Kim - BMC cancer, 2011 - Springerhttps://link.springer.com/article/10.1186/1471-2407-11-225 Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo YC Song , AH Chou, A Homhuan - Journal of Leukocyte , 2011 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/90/2/323/6960320 Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical WMJ Schoell, R Mirhashemi, B Liu, MF Janicek - Gynecologic , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S009082589995504X Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial WJ Van Driel, ME Ressing, GG Kenter - European journal of , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0959804999000489 Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations WF Cheng, CN Lee, YN Su, MC Chang - , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02126.x Linear epitope prediction in HPV type 16 E7 antigen and their docked interaction with human TMEM 50A structural model U Srivastava , S Singh, B Gautam , P Yadav - , 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498776/ Use of fluorogenic histocompatibility leukocyte antigen-A* 0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous SJ Youde, PRR Dunbar , EML Evans, AN Fiander - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/2/365/506850 Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line SJ Youde, CM McCarthy, KJ Thomas - Journal of Cancer, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20779 A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo SH Tu, HI Huang , SI Lin, HY Liu, YP Sher - Journal of , 2012 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/FullText/2012/04000/A_Novel_HLA_A2_restricted_CTL_Epitope_of.4.aspx Study on phenotype and function of antigen-specific CD8+ cytotoxic T cells induced by HPV 16 E7 peptide in vitro. QQF Qian QiFeng, LFG Li FangGu, LQ Li Qing - 2010 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20103227892 detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic N Cools , P Ponsaerts , M Lenjou, G Nijs - Molecular Cancer, 2006 - Springerhttps://link.springer.com/article/10.1186/1476-4598-5-49 A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7 (11-20) cytotoxic T lymphocyte epitope MWJ Schreurs, EWM Kueter, KBJ Scholten - Vaccine, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X05003804 Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway ML Mora-GarcacaÂa , LR acaÂvila-Ibarra, R GarcacaÂa-Rocha - Cellular , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874917301363 Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone ML Mora-GarcacaÂa , A Duenas-Gonzalez - Journal of Translational , 2006 - Springerhttps://link.springer.com/article/10.1186/1479-5876-4-55 Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions M de Lourdes Mora-GarcacaÂa , R GarcacaÂa-Rocha - Journal of Translational , 2016 - Springerhttps://link.springer.com/article/10.1186/s12967-016-1057-8 Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type M Alexander, ML Salgaller, E Celis, A Sette - American journal of , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002937896701102 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H HoÃËhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization HW Chen, CH Leng, HY Liu, WF Cheng - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.4161/cbt.8.21.9732 Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A* 0201-restricted T-cell peptides in cervical cancer patients DW Liu, YC Yang, HF Lin, MF Lin, YW Cheng - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02256-06 Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens DB Keskin , B Reinhold , SY Lee, G Zhang - Frontiers in , 2011 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2011.00075/full Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. CWF Cheng WenFang, LCN Lee ChienNan - 2005 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20053066734 Activated B cells mediate efficient expansion of rare antigen-specific T cells C Zentz, M Wiesner, S Man, B Frankenberger - Human immunology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885906006112 Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy C Thornburg, D Boczkowski, E Gilboa - Journal of , 2000 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2000/07000/induction_of_cytotoxic_t_lymphocytes_with.4.aspx A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers B Hu, R Wang, D Wu, R Long, J Fan, Z Hu - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202302340 Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide AX Yang, N Chong, Y Jiang, J Catalano, RK Puri - PloS one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086306H-Ser-Leu-Ile-Gly-Arg-Leu-NH2
CAS:H-Ser-Leu-Ile-Gly-Arg-Leu-NH2 is a cyclase inhibitor that binds to the neurokinin 1 receptor, leading to an inhibition of the release of inflammatory substances in the bowel. HSLIGRL can also inhibit epidermal growth factor (EGF), which suppresses inflammation and cell proliferation. HSLIGRL also inhibits inflammatory bowel disease by decreasing the production of prostaglandins, which are chemical messengers involved in pain and inflammation. HSLIGRL has been shown to be effective against low potency benzalkonium chloride, which is often used as a preservative in pharmaceuticals. This compound has been shown to reduce inflammation by inhibiting proinflammatory cytokines such as TNFα and IL1β.Fórmula:C29H56N10O7Pureza:Min. 95%Peso molecular:656.83 g/mol